Quidel | QDEL - Sales Revenues


Quidel reported $630.9M in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
Abbott USD 12.59B 1.43B Jun/2026
Agilent USD 1.84B 37M Mar/2026
Becton, Dickinson and Co. USD 5B 300M Jun/2026
Bruker USD 838.5M 15.1M Jun/2026
Cerus USD 50.81M 4.79M Dec/2024
Charles River Laboratories USD 1000M 4.2M Jun/2026
Danaher USD 6.3B 350M Jun/2026
Haemonetics USD 339M 7M Jun/2026
Illumina USD 1.16B 70M Jun/2026
IQVIA Holdings USD 4.37B 220M Jun/2026
Merit Medical Systems USD 418.8M 36.9M Jun/2026
Mettler Toledo International USD 1.03B 82.87M Jun/2026
Myriad Genetics USD 190.7M 9.7M Jun/2026
Neogen USD 225.3M 14.1M Mar/2026
OraSure Technologies USD 26.76M 322K Dec/2025
Pacific Biosciences Of California USD 44.64M 6.2M Dec/2025
Quidel USD 630.9M 10.9M Jun/2026
Revvity USD 729.68M 18.68M Jun/2026
STAAR Surgical USD 93.5M 145.9M Mar/2026
Thermo Fisher Scientific USD 11.99B 980M Jun/2026
Waters USD 1.64B 370M Jun/2026